Investor Relations

About Cantourage

Cantourage is a leading European medical cannabis company. The Berlin-based company was founded in 2019 by industry pioneers Norman Ruchholtz, Dr. Florian Holzapfel and Patrick Hoffman. Cantourage enables producers from all over the world to become part of the rapidly growing European medical cannabis market in a faster and more cost-effective way, while guaranteeing and developing the highest European quality standards. The company offers products in all relevant market segments: dried flowers, extracts, Dronabinol and pharma-grade Cannabidiol.

Financial calendar

  • May 2023: Financial statements 31/12/2022
  • June 2023: Annual general meeting 2023
  • October 2023: Half-year financial statements 30/06/2023

Press releases